<Entry>
<Accession>O60583</Accession>
        <ProteinName>Cyclin-T2</ProteinName>
        <GeneName>CCNT2</GeneName>
        <OS_id>9606</OS_id>
        <ReferenceProteome>None</ReferenceProteome>
        <SubcellularLocation>
<Location>SL-0198</Location>
<Comments>Cytoplasm, perinuclear region {ECO:0000250|UniProtKB:Q7TQK0}. Nucleus {ECO:0000250|UniProtKB:Q7TQK0}. Note=Nucleus in differentiating cells. {ECO:0000250|UniProtKB:Q7TQK0}.</Comments>
</SubcellularLocation>
<CrossReferences>
<CrossReference>
<Database>UNIPROT</Database>
<ID>O60583</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>A8KA48</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>D3DP73</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>D3DP74</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>O60582</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>Q29R66</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>Q53SR4</ID>
</CrossReference>
<CrossReference>
<Database>UNIPROT</Database>
<ID>Q5I1Y0</ID>
</CrossReference>
<CrossReference>
<Database>PDB</Database>
<ID>2IVX</ID>
</CrossReference>
<CrossReference>
<Database>Pfam</Database>
<ID>PF00134</ID>
</CrossReference>
<CrossReference>
<Database>OMIM</Database>
<ID>603862</ID>
</CrossReference>
<CrossReference>
<Database>DisGeNET</Database>
<ID>905</ID>
</CrossReference>
</CrossReferences>
<Function>Regulatory subunit of the cyclin-dependent kinase pair (CDK9/cyclin T) complex, also called positive transcription elongation factor B (P-TEFB), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (carboxy- terminal domain) of the large subunit of RNA polymerase II (RNAP II) (PubMed:9499409, PubMed:15563843). The activity of this complex is regulated by binding with 7SK snRNA (PubMed:11713533). Plays a role during muscle differentiation; P-TEFB complex interacts with MYOD1; this tripartite complex promotes the transcriptional activity of MYOD1 through its CDK9-mediated phosphorylation and binds the chromatin of promoters and enhancers of muscle-specific genes; this event correlates with hyperphosphorylation of the CTD domain of RNA pol II (By similarity). In addition, enhances MYOD1-dependent transcription through interaction with PKN1 (PubMed:16331689). Involved in early embryo development (By similarity). {ECO:0000250|UniProtKB:Q7TQK0, ECO:0000269|PubMed:11713533, ECO:0000269|PubMed:15563843, ECO:0000269|PubMed:16331689, ECO:0000269|PubMed:9499409}. (Microbial infection) Promotes transcriptional activation of early and late herpes simplex virus 1/HHV-1 promoters. {ECO:0000269|PubMed:21509660}.</Function>
<Interactions>
<Interaction>
<Partner>A0A3Q0PRD7</Partner>
<IntAct>EBI-2836754</IntAct>
<Score>0.00</Score>
</Interaction>
<Interaction>
<Partner>O95402</Partner>
<IntAct>EBI-4324040</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>Q9UHB7</Partner>
<IntAct>EBI-4324092</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>O00472</Partner>
<IntAct>EBI-4324079</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>P42568</Partner>
<IntAct>EBI-4324106</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>P50750</Partner>
<IntAct>EBI-4324121</IntAct>
<Score>0.85</Score>
</Interaction>
<Interaction>
<Partner>O60885</Partner>
<IntAct>EBI-9077135</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>Q6NYC1</Partner>
<IntAct>EBI-9077105</IntAct>
<Score>0.40</Score>
</Interaction>
<Interaction>
<Partner>Q16659</Partner>
<IntAct>EBI-12502733</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>A3KMF4</Partner>
<IntAct>EBI-11085933</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>Q9ERL0</Partner>
<IntAct>EBI-11086053</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>Q9HB65</Partner>
<IntAct>EBI-21631556</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>Q9P0M6</Partner>
<IntAct>EBI-21731516</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>Q96MH2</Partner>
<IntAct>EBI-21764590</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>O94992</Partner>
<IntAct>EBI-21776048</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>Q00534</Partner>
<IntAct>EBI-21776141</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>P14404</Partner>
<IntAct>EBI-21026252</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>Q12802</Partner>
<IntAct>EBI-25409729</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>Q07139</Partner>
<IntAct>EBI-25410964</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>P83105</Partner>
<IntAct>EBI-25745135</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>O60583</Partner>
<IntAct>EBI-25684887</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>A0A0F6B063</Partner>
<IntAct>EBI-27033283</IntAct>
<Score>0.35</Score>
</Interaction>
<Interaction>
<Partner>D0ZRB2</Partner>
<IntAct>EBI-27033344</IntAct>
<Score>0.35</Score>
</Interaction>
</Interactions>
<OntologyTerms>
<Ontology>GO:0008024</Ontology>
<Ontology>GO:0005829</Ontology>
<Ontology>GO:0005654</Ontology>
<Ontology>GO:0005634</Ontology>
<Ontology>GO:0048471</Ontology>
<Ontology>GO:0005886</Ontology>
<Ontology>GO:0097322</Ontology>
<Ontology>GO:0003682</Ontology>
<Ontology>GO:0061575</Ontology>
<Ontology>GO:0016538</Ontology>
<Ontology>GO:0019901</Ontology>
<Ontology>GO:0070063</Ontology>
<Ontology>GO:0001223</Ontology>
<Ontology>GO:0007049</Ontology>
<Ontology>GO:0051301</Ontology>
<Ontology>GO:0019085</Ontology>
<Ontology>GO:0019086</Ontology>
<Ontology>GO:0032786</Ontology>
<Ontology>GO:0045944</Ontology>
<Ontology>GO:0032968</Ontology>
<Ontology>GO:0006468</Ontology>
<Ontology>GO:0000079</Ontology>
<Ontology>GO:0051147</Ontology>
<Ontology>GO:0006357</Ontology>
<Ontology>GO:0007519</Ontology>
<Ontology>GO:0006366</Ontology>
</OntologyTerms>
<Topology>
        <Type>Unknown</Type>
        <Source>UniProt</Source>
        <Annotation>Sequence Analysis</Annotation>
        </Topology>
<Sequence>MASGRGASSRWFFTREQLENTPSRRCGVEADKELSCRQQAANLIQEMGQRLNVSQLTINTAIVYMHRFYMHHSFTKFNKNIISSTALFLAAKVEEQARKLEHVIKVAHACLHPLEPLLDTKCDAYLQQTQELVILETIMLQTLGFEITIEHPHTDVVKCTQLVRASKDLAQTSYFMATNSLHLTTFCLQYKPTVIACVCIHLACKWSNWEIPVSTDGKHWWEYVDPTVTLELLDELTHEFLQILEKTPNRLKKIRNWRANQAARKPKVDGQVSETPLLGSSLVQNSILVDSVTGVPTNPSFQKPSTSAFPAPVPLNSGNISVQDSHTSDNLSMLATGMPSTSYGLSSHQEWPQHQDSARTEQLYSQKQETSLSGSQYNINFQQGPSISLHSGLHHRPDKISDHSSVKQEYTHKAGSSKHHGPISTTPGIIPQKMSLDKYREKRKLETLDLDVRDHYIAAQVEQQHKQGQSQAASSSSVTSPIKMKIPIANTEKYMADKKEKSGSLKLRIPIPPTDKSASKEELKMKIKVSSSERHSSSDEGSGKSKHSSPHISRDHKEKHKEHPSSRHHTSSHKHSHSHSGSSSGGSKHSADGIPPTVLRSPVGLSSDGISSSSSSSRKRLHVNDASHNHHSKMSKSSKSSGSSSSSSSSVKQYISSHNSVFNHPLPPPPPVTYQVGYGHLSTLVKLDKKPVETNGPDANHEYSTSSQHMDYKDTFDMLDSLLSAQGMNM</Sequence>
        <SequenceLength>730</SequenceLength>
        </Entry>